Tris Pharma, Inc.   Report issue

For profit Phase 3
Founded: Monmouth Junction NJ United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2014
NCT02083783
First Marketed Drug
2009
ibuprofen (motrin)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Tris Pharma, Inc. | TRIS PHARMA INC